Member Info for WengerOut

ISA allowance is £20,000 a year.
£13,200 is the amount you earn before paying tax.

If you want a further chat on the company Ring Megan Ray or Tim Blythe on +44 (0) 20 7138 3203, they have responded to me in the past. They are Amur’s Public Relations and you get a better response from them rather than the Nomad.

Myles McNulty today -
There is a real possibility that #AVCT will publish the sensitivity / specificity of its AN-sample LFT before clinical validation even begins, IF the results from the initial testing with clinical samples (ongoing right now) are positive.
This could be within the next two weeks.

The ducks are being lined up, take your positions!

https://twitter.com/avacta/status/1330771622593179648?s=21

Just filter these sad people.

... it’s what the low life want, just filter and ignore.

With BioNTech and Moderna having validated the field of mRNA with seemingly highly effective vaccines - now I think is a good time to remind fellow @avacta investors that $MRNA and #AVCT are already working on mRNA-Affimer-based therapeutics.

From p.18:

avacta.com/wp-content/upl

Spot on jdt1990, the only ones that are fretting here are the short term traders/chancers who are over exposed and desperate for their Xmas money! Fook ‘em, take your time AS and get things done correctly!

By dalep716

“So, at the Stifel Coporate Event Al answered my question relating to Clinical Validation of BAMS. The phrase he used was that "we have the samples and data so that Clinical Validation will completed in the immediate future". Perhaps I won't top slice again just now!”

#AVCT buyers reappearing after Stifel broadcast.

Investors realising that @avacta - through sales of both own-branded LFTs, and of LFTs of major IVD players who might license Affimers to replace their mAbs and enhance their tests - could ultimately achieve unit sales of 100m+ pm

Another part of the jigsaw complete!

Everything will be through AVCT in regards to Coronavirus

.. it will be one of those, where were you moments.
Imagine reflecting back and saying, I was in between trades! LOL

AS needs to speak now as a few £500 T+20 traders have overstretched themselves! #Chancers

.. to people who put silly headers like the RNS one below, it keeps the misleading header at the top of the read when it should be just disregarded.

Why people expect RNS’s the day after every deadline I do not know, let them get on with it. There is no better pharma out there to be invested in at the moment.

He is a new joiner who is deramping and wants you to respond to his header to keep it high profile, sad excuse of a man.

So has the subsoil law changed in 2 months? Mmmm...

This was what Robin said in April -

The Directors are confident that the work will be completed on the licence in time. However, if the lockdown is extended indefinitely; and if the Company is unable to complete the associated work programme before the deadline, and if an extension to that deadline is not granted by the Russian authorities, it would put the licence at significant risk. The Company will continue to update investors regularly and in detail on its progress.